Skip to main content
DNA Labs India

HLA - Panel Reactive IgG Antibodies (PRA) Screen Test

DNA Labs India | ISO 9001:2015 Certified

HLA - Panel Reactive IgG Antibodies (PRA) Screen Test

Short Name: HLA PRA Screen

Also known as: PRA Screen Test, Panel Reactive Antibody Screen, HLA Antibody Screen, PRA IgG Screen, Sensitization Screen

HLA - Panel Reactive IgG Antibodies (PRA) Screen Test test available at DNA Labs India for ₹8,500. Uses Luminex X-Map Technology on Serum samples. Results in Results are typically available within 10–12 working days from sample collection. Reports can be accessed through the online patient portal, received via email, or delivered through WhatsApp.. Free home collection in 300+ cities across India.

ScreeningAll Ages🏠 Home Collection

Overview

The primary purpose of the HLA PRA Screen Test is to evaluate the degree of immunological sensitization in patients awaiting organ transplantation. By identifying preformed IgG antibodies against Class I and Class II HLA antigens, the test helps transplant teams assess the risk of hyperacute and acute antibody-mediated rejection. The results guide organ allocation decisions, donor-recipient matching, desensitization protocol planning, and the consideration of alternative transplant strategies such as paired kidney exchange programs.

Test Code
799
CPT Code
86812
ICD Code
Z94.0
Price
₹8,500
Sample Type
Serum
Result Time
Results are typically available within 10–12 working days from sample collection. Reports can be accessed through the online patient portal, received via email, or delivered through WhatsApp.
Fasting Required
No
Method
Luminex X-Map Technology
Step 1

Sample Collection

Collect specimen preferably 48 hours after the last dialysis session. Provide a brief clinical history including transfusion history, prior transplant history, and pregnancy history. No fasting is required. Inform the phlebotomist about any ongoing immunosuppressive or immunoglobulin therapy.

Method: Venipuncture

Step 2

Laboratory Analysis

A standard venipuncture will be performed. Approximately 3 mL of blood will be drawn into a Serum Separator Tube (SST). The procedure typically takes less than 5 minutes.

Step 3

Report Delivery

Apply gentle pressure to the puncture site with cotton wool for 3–5 minutes. No specific post-collection restrictions apply. Resume normal activities immediately.

Timeline: Results are typically available within 10–12 working days from sample collection. Reports can be accessed through the online patient portal, received via email, or delivered through WhatsApp.

Patient Instructions

1
Before the Test:No fasting is required. Collect the blood specimen preferably 48 hours after the last dialysis session. Provide your transplant team with a brief clinical history including any history of blood transfusions, prior organ transplants, pregnancies, or immunosuppressive therapy. Inform the healthcare provider about any current medications.
2
During the Test:A healthcare professional will perform a standard venipuncture to collect approximately 3 mL of blood into a Serum Separator Tube (SST). The blood draw typically takes less than 5 minutes. You may feel a brief needle prick during collection.
3
After the Test:After blood collection, gentle pressure will be applied to the puncture site. A small bandage will be placed. You can resume normal activities immediately. No post-procedure restrictions are required. The sample will be processed using Luminex X-Map technology in the laboratory.

About This Test

Who Should Get This Test

The primary purpose of the HLA PRA Screen Test is to evaluate the degree of immunological sensitization in patients awaiting organ transplantation. By identifying preformed IgG antibodies against Class I and Class II HLA antigens, the test helps transplant teams assess the risk of hyperacute and acute antibody-mediated rejection. The results guide organ allocation decisions, donor-recipient matching, desensitization protocol planning, and the consideration of alternative transplant strategies such as paired kidney exchange programs.

How to Prepare

  • Collect specimen preferably 48 hours after the last dialysis session
  • Use a Serum Separator Tube (SST) for blood collection
  • Minimum volume required: 1.5 mL serum; preferred volume: 3 mL serum
  • Ship specimen refrigerated (2–8°C) or frozen (-20°C)
  • Provide brief clinical history including transfusion history, prior transplant, and pregnancy details
  • Label the specimen accurately with patient name, date, and time of collection

Doctor's Notes

"The HLA PRA Screen is a critical first step in evaluating transplant sensitization. Patients with elevated PRA levels have a narrower pool of compatible donors, which can significantly increase waiting time for organ allocation. Early screening allows the transplant team to plan desensitization protocols, consider paired kidney exchange programs, and optimize immunosuppressive strategies before transplantation. I recommend all potential organ transplant recipients undergo PRA screening as part of their baseline evaluation."

Test Parameters & Specifications

Sample TypeSerum
Sample Volume3 mL (1.5 mL minimum)
ContainerSST (Serum Separator Tube)
Collection MethodVenipuncture

Sample Stability

Room Temperature (15–25°C)
Refrigerated (2–8°C)
Frozen (-20°C or below)
Sample Rejection Criteria:
  • Hemolyzed, icteric, or severely lipemic samples
  • Specimen collected in incorrect tube type (non-SST)
  • Insufficient sample volume (less than 1.5 mL serum)
  • Specimen stored at room temperature for more than 2 hours
  • Mislabeled or unlabeled specimens
  • Specimen collected less than 48 hours post-dialysis without documented justification

Understanding Your Results

The HLA PRA Screen Test results indicate whether a patient has preformed IgG antibodies against HLA antigens, which is a measure of immunological sensitization. Results are reported as reactive or non-reactive for Class I and Class II HLA antibodies. A non-reactive result suggests low sensitization and a broader pool of potentially compatible donors. A reactive result indicates the presence of HLA-specific antibodies and warrants further quantitative testing to determine the exact PRA percentage and antibody specificity profile.
📊

No detectable IgG antibodies against HLA Class I and/or Class II antigens. This indicates a low degree of sensitization, suggesting a broader pool of compatible organ donors and a lower risk of antibody-mediated rejection.

Result type: Non-Reactive (Negative)

📊

Low-level HLA antibody reactivity detected. The patient may have a mild degree of sensitization against HLA antigens, possibly from prior blood transfusions, pregnancy, or previous transplant exposure.

Result type: Reactive – Low Level

📊

Moderate to strong HLA antibody reactivity detected. The patient is significantly sensitized, which narrows the compatible donor pool and increases the risk of hyperacute and acute antibody-mediated rejection.

Result type: Reactive – Moderate to Strong

⚠️ When to Consult a Doctor:

Consult your transplant nephrologist or transplant surgeon if your PRA screen result is reactive. If you are currently on an organ transplant waiting list and experience changes in your clinical condition, receive blood transfusions, or become pregnant, inform your transplant team as these events may affect your sensitization status and warrant repeat testing.

Limitations

  • This is a screening test; positive results require quantitative PRA testing and HLA antibody specificity analysis
  • The test detects only IgG antibodies and does not assess IgM or IgA anti-HLA antibodies
  • Results do not specify individual donor compatibility; a prospective crossmatch test is additionally required
  • False negatives may occur in patients with very low antibody titers below the assay detection threshold
  • Results must be interpreted in conjunction with clinical history and additional transplant immunology workup

Risks & Considerations

  • Minor bruising or swelling at the venipuncture site
  • Slight discomfort or pain during needle insertion
  • Very rare risk of infection at the puncture site
  • Minimal risk of lightheadedness or fainting during blood draw

Interfering Factors

  • Hemolyzed or lipemic samples may affect test accuracy
  • Specimen collection within 48 hours of dialysis may yield inaccurate results
  • Recent blood transfusions can transiently alter antibody levels
  • Administration of immunoglobulin therapy or certain immunosuppressive drugs may interfere with results
  • Improper sample storage or delayed transport can compromise specimen integrity

Compare With Similar Tests

TestHLA - Panel Reactive IgG Antibodies (PRA) Screen TestHLA PRA QuantitativeHLA Crossmatch TestHLA Typing
ComparisonHLA - Panel Reactive IgG Antibodies (PRA) Screen TestThe PRA Screen is a qualitative/semi-qualitative test that detects the presence of HLA antibodies. The PRA Quantitative test provides an exact percentage of panel reactivity, indicating the proportion of the donor population against which the patient has antibodies.While the PRA Screen assesses sensitization against a broad panel of HLA antigens, the crossmatch test directly evaluates donor-recipient compatibility by mixing the recipient's serum with the specific donor's lymphocytes.HLA Typing identifies the patient's own HLA antigen profile, while the PRA Screen detects antibodies the patient has developed against foreign HLA antigens. Both are essential components of pre-transplant evaluation.

Frequently Asked Questions

What is the HLA PRA Screen Test?
The HLA PRA Screen Test is a blood test that detects the presence of preformed IgG antibodies against Human Leukocyte Antigens (HLA) in the blood. It is primarily used as a pre-transplant evaluation tool to assess immunological sensitization in patients awaiting organ transplantation.
Why is the HLA PRA Screen Test important before organ transplantation?
The HLA PRA Screen Test helps transplant teams determine the degree of a patient's sensitization to HLA antigens. Patients with high levels of preformed antibodies have a narrower pool of compatible donors and a higher risk of antibody-mediated rejection. The test guides donor selection, organ allocation, and desensitization strategies.
What does a reactive PRA screen result mean?
A reactive PRA screen result means that HLA-specific IgG antibodies have been detected in your blood. This indicates immunological sensitization, which may have occurred due to prior blood transfusions, pregnancies, or previous organ transplants. A reactive result warrants further quantitative PRA testing to determine the exact antibody levels and specificity.
What is the difference between PRA Screen and PRA Quantitative testing?
The PRA Screen Test is a qualitative or semi-qualitative screening test that detects the presence or absence of HLA antibodies. The PRA Quantitative Test provides a specific percentage of panel reactivity, indicating the proportion of the population against which the patient has antibodies. Quantitative testing is recommended when the screen result is moderately or strongly positive.
Is fasting required for the HLA PRA Screen Test?
No, fasting is not required for the HLA PRA Screen Test. However, it is recommended that the blood specimen be collected preferably 48 hours after the last dialysis session to obtain accurate results.
What is the cost of the HLA PRA Screen Test in India?
The HLA PRA Screen Test at DNA Labs India costs Rs 8500. This price includes free home sample collection across India, Luminex X-Map technology-based analysis, and digital report delivery via online portal, email, and WhatsApp.
How long does it take to get the HLA PRA Screen Test results?
The results of the HLA PRA Screen Test are typically available within 10–12 working days from the date of sample collection. The report will be shared through the online patient portal, email, and WhatsApp.
What sample is required for the HLA PRA Screen Test?
The HLA PRA Screen Test requires a 3 mL blood sample (minimum 1.5 mL) collected in a Serum Separator Tube (SST) via venipuncture. The sample should be shipped refrigerated or frozen and is preferably collected 48 hours after the last dialysis session.
Who should get the HLA PRA Screen Test done?
The HLA PRA Screen Test is recommended for patients who are on the waiting list for organ transplantation (kidney, liver, heart, lung, or pancreas), sensitized individuals with a history of blood transfusions, previous transplants or pregnancies, and patients being evaluated for desensitization protocols or paired kidney exchange programs.
Can a person with a high PRA percentage still undergo organ transplantation?
Yes, a person with a high PRA percentage can still undergo organ transplantation, but the process may be more complex. The transplant team may consider desensitization protocols, highly matched donor selection, paired kidney exchange programs, or extended waiting times to find a compatible organ. A prospective crossmatch test is mandatory before transplantation.
Is home sample collection available for the HLA PRA Screen Test?
Yes, DNA Labs India offers free home sample collection for the HLA PRA Screen Test. You can book the test online, and a trained phlebotomist will visit your location to collect the blood sample. Home collection is available in over 400 cities across India.
How is the HLA PRA Screen Test performed?
The test is performed using Luminex X-Map technology, a multiplex bead-based immunoassay. Patient serum is incubated with microbeads coated with purified HLA antigens. If HLA-specific antibodies are present, they bind to the beads, which are then detected using fluorescently labeled secondary antibodies. The technology allows simultaneous screening for antibodies against both Class I and Class II HLA antigens.
Worried about the process? Our certified phlebotomists collect thousands of samples every month across India. The process takes under 5 minutes and is virtually painless. Questions? Message us on WhatsApp — we're here 7 days a week.

Related Tests

For Hospitals & Clinics

Reference Laboratory Services

We serve as a reference laboratory for hospitals and clinics across India. Send samples from your facility with same-day pickup, priority processing, and results delivered through our online portal. Competitive institutional pricing available.

LIMS Integration

Your Data Privacy

Your medical data is protected under Indian law.

Stored in India: All patient records are stored on servers located in India. No data is transferred outside the country.

DPDP Act Compliant: Under the Digital Personal Data Protection Act 2023, you can request deletion of your records at any time by contacting support.

Book Your Test

Enter your details and we'll connect you within 15 minutes.

🧬

Quick Connect

Enter your mobile number and we’ll connect you with the team.

+91

✅ Connecting you now...

🔒 Your number is used to respond to this request.